Partner Headlines - IBB

  1. Tectonic Forces Create Shifts in the Market-Scape

    TalkMarkets
  2. Biotech Stock Euphoria Has Turned To A Massive Sell-Off - Here's ...

    TalkMarkets
  3. Stock Exchange: Model Picks Teach Us To Manage Risk

    TalkMarkets
  4. The Race To Not Buy At The Highs Nor Sell At The Lows

    TalkMarkets
  5. Market’s Eyes That Cannot See

    TalkMarkets
  6. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled ...

    TalkMarkets
  7. A Market With Purple Gratitude In Advance Of Rain

    TalkMarkets
  8. Gather Ye Rosebuds Before The Market Flies Multiply

    TalkMarkets
  9. Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink

    TalkMarkets
  10. Market Leader About To Jump Ship And Breakdown?

    TalkMarkets
  11. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech? ...

    TalkMarkets
  12. Channel Tops Can Wring Out Like A Saturated Sponge

    TalkMarkets
  13. The S&P 500 Signs A Year-Long Contract To Gig

    TalkMarkets
  14. 4 Steps For Planning Your Next Trades

    TalkMarkets
  15. Does Your ETF Portfolio Need A Trump Transformation?

    TalkMarkets
  16. Leading Indicator, Facing Key Breakout Test

    TalkMarkets
  17. Dry Ships On The Water Very Free And Easy

    TalkMarkets
  18. Gremlins That Might Appear At 19K In The Dow

    TalkMarkets
  19. Market's Majestic Mountains With Fissures

    TalkMarkets
  20. Three Quick and Easy Profit Plays to Make Right Now

    TalkMarkets
  21. Everybody Trades With Their Fingers Crossed

    TalkMarkets
  22. AskSlim Market Week - 11/11/16

    TalkMarkets
  23. 4 Best Healthcare Mutual Funds to Profit from Trump Win

    TalkMarkets
  24. 5 Stocks To Watch On Icahn & Paulson's Gain From Trump Win

    TalkMarkets
  25. T2108 Update – Trump Trades: Divergences and Rotations

    TalkMarkets
  26. This Bull Survived The Harshest Environment

    TalkMarkets
  27. The iShares Nasdaq Biotechnology (IBB) Overcomes Its First Bash

    TalkMarkets
  28. The Daily Shot And Data — Thursday, Nov. 10

    TalkMarkets
  29. The Day After

    TalkMarkets
  30. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets
  31. Trump Triumphs

    TalkMarkets
  32. The Market Bows, But Is That Gesture Sincere?

    TalkMarkets
  33. “Hey Tonight, Gonna Be Tonight...”

    TalkMarkets
  34. Where To Find The Best Trades After The Election, Regardless…

    TalkMarkets
  35. Make-Or-Break: 5 Great Investment Ideas For 2017

    TalkMarkets
  36. The Market Whisperer Takes Investors to a Rodeo

    TalkMarkets
  37. VBI Vaccines – An Idea For Investors Who Want To Avoid The Index ...

    TalkMarkets
  38. Investors Could Sure Use a Market Whisperer

    TalkMarkets
  39. Safety In The Herd Until After The Election

    TalkMarkets
  40. The Market's Trail To The White House

    TalkMarkets
  41. Will We Hold It Wednesday - Dow 18,000 Edition

    TalkMarkets
  42. Nature Erodes; The Market Corrodes

    TalkMarkets
  43. Biotech Meltdown: Financial Metrics Offer Few Clues For What ...

    TalkMarkets
  44. What Does "Shake It Up" Mean For Your Money?

    TalkMarkets
  45. T2108 Update – Divergences Weigh Further on the Stock Market

    TalkMarkets
  46. Biotech Erosion Persisting

    TalkMarkets
  47. A Giant Rat: The Market's Unexpected Trick Or Treater

    TalkMarkets
  48. Gilead Sciences, Inc.: Why You Should Go Long On Gilead Stock?

    TalkMarkets
  49. Stagflation: Terror and Awe

    TalkMarkets
  50. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  51. Market's Fighting For Its Life Inside A Thriller

    TalkMarkets
  52. 6 Simple Strategies To Trade The Wolf's Meow

    TalkMarkets
  53. Trading the Market Without an Authorized Guide

    TalkMarkets
  54. Is The Bull Market’s Tide Coming In or Going Out?

    TalkMarkets
  55. Alert: Biotechnology And Health Sector Testing Long Time Support

    TalkMarkets
  56. Bio-Tech; In More Trouble If This Fails, Says Joe Friday

    TalkMarkets
  57. Bio-Tech; In More Trouble If This Fails

    TalkMarkets
  58. The Market's Equal And Opposing Forces

    TalkMarkets
  59. A Solar-Powered Glow-In-The-Dark Market Rallysaurus

    TalkMarkets
  60. Somewhere, Over The Tech Rainbow

    TalkMarkets
  61. ETFs To Play As Biotech Juggles Election & Earnings

    TalkMarkets
  62. A Fresh Breakdown For iShares Nasdaq Biotechnology

    TalkMarkets
  63. AskSlim MarketWeek - 10/14/16

    TalkMarkets
  64. Jeepers Creepers, Who Wants To Eat Bull's Peepers?

    TalkMarkets
  65. Gremlins at 18k in the Dow Versus the Rallysaurus

    TalkMarkets
  66. Fed Minutes Show Conflicted Central Bank

    TalkMarkets
  67. Biotechnology Bear Market: Trends To Watch For A 2016 Q4 Rally

    TalkMarkets
  68. Illumina Misses Revenue Forecast Causing Collateral Damage To ...

    TalkMarkets
  69. Technology Spins A Ghoulish Fugue

    TalkMarkets
  70. Dow Jones Industrial Average Today Climbs As Oil Prices Surge

    TalkMarkets
  71. Just A Rallysaurus Monday

    TalkMarkets
  72. The Market's Indistinct Absurdity

    TalkMarkets
  73. Biotech Stocks Recovering From Last Week’s Free Fall

    TalkMarkets
  74. Enjoy The Bounty And Prepare For Frost

    TalkMarkets
  75. A Three-Headed Dog Not Medusa Spooks the Market

    TalkMarkets
  76. If Medusa Meets The Market's Rallysaurus

    TalkMarkets
  77. Good News Is Bad News For October

    TalkMarkets
  78. Will the Market Scratch on the Door or Pee on the Rug?

    TalkMarkets
  79. Market Has Bloodshot Eyes

    TalkMarkets
  80. Rayno 2016 Life Science Portfolio Update

    TalkMarkets
  81. Picks And Pans For 9/29/2016

    TalkMarkets
  82. The Market Stands at a Frontier

    TalkMarkets
  83. Where Will The Next Market Leading Stocks Come From?

    TalkMarkets
  84. If The Sun Shines, The Market Should Warm Up

    TalkMarkets
  85. Biotech Stocks Pause At Resistance: IBB

    TalkMarkets
  86. The Market Spins A Fragile Web

    TalkMarkets
  87. Renewable is the Market's New Sustainable

    TalkMarkets
  88. The Market Lives, Dies And Lives Again!

    TalkMarkets
  89. Trending on ETFdb.com: Politics and Central Banks Move Markets

    ETFdb
  90. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For ...

    Investors Business Daily
  91. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or ...

    Investors Business Daily
  92. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits ...

    IBD
  93. TickerTags Data Shows Drug Price Debate Still Trending

    Benzinga
  94. Even With Volatility, Investors Love Biotech ETFs

    Benzinga
  95. Equal Weighting Works For This Industry ETF

    Benzinga
  96. Biotechs Sell Off Hard, But Indexes Cut Their Losses

    IBD
  97. Biotech ETFs: Buy, Buy, Buy?

    Benzinga
  98. Social Media Beat: What Experts And The Crowd Think Of Biotechs, ...

    Benzinga
  99. Biotech Bears Spark Good Vibes For These ETFs

    Benzinga
  100. Techs Erase Early Gains; Apple, Facebook Lead Nasdaq 100 Lower

    IBD
Trading Center